Navigation Links
DePuy ASR Lawsuit News: Bernstein Liebhard LLP Notes Issuance of New Order in Federal DePuy ASR Hip Recall Litigation
Date:12/6/2013

New York, New York (PRWEB) December 06, 2013

Thousand of DePuy ASR hip lawsuits (http://www.consumerinjurylawyers.com/DePuy/) filed on behalf of individuals who allegedly suffered metallosis, pseudotumors, premature device failure and other complications caused by the recalled devices are continuing to move forward in a multidistrict litigation underway in U.S. District Court, Northern District of Ohio, Bernstein Liebhard LLP reports. According to an Order filed on December 5, 2013, the Court has amended an earlier Case Management Order pertaining to the Defendants’ Master Answer. Among other things, the new Order Stipulates that the Master Answer is now deemed filed and immediately applicable and responsive to all DePuy ASR lawsuits claims currently pending in the litigation. (In re: DePuy Orthopaedics, Inc. ASR Hip Implant Products Liability Litigation – MDL 2197)

“Our Firm is representing hundreds of DePuy ASR lawsuit clients in this litigation. We are currently working to assist our clients who may be eligible for the recently announced DePuy ASR settlement to determine their best course of action,” says Bernstein Liebhard LLP, a nationwide law firm representing the victims of defective drugs and medical devices. The Firm continues to offer free legal evaluations to individuals who may have been harmed by devices included in the DePuy ASR recall.

DePuy ASR Settlement
The issuance of this new Order follows the November 19th announcement in the Northern District of Ohio of a proposed agreement to settle many of the DePuy ASR lawsuits now pending in courts around the country. According to court documents, if the settlement is accepted by at least 94% of eligible plaintiffs, those claimants would be entitled to a base award of $250,000. That award could be reduced, however, depending on certain other factors, including their prior medical history. Other circumstances could entitle plaintiffs to a supplemental award if they, for example, required multiple revision surgeries, or if they experience “certain extraordinary injuries” in the future. Those eligible for the proposed DePuy ASR settlement include recipients of the recalled hip who had an ASR hip replaced for a reason related to the recall no later than August 31, 2013.

According to The New York Times, if the DePuy ASR settlement is finalized, it could resolve roughly 8,000 of the 12,000 claims filed against Johnson & Johnson and DePuy Orthopaedics since the hip recall was announced in 2010. Those who are not eligible for compensation under its terms may still pursue DePuy ASR lawsuits against the company.*

Recipients of ASR hips who suffered serious complications that may have been caused by the device are urged to contact Bernstein Liebhard LLP today to learn more about the proposed settlement, or to discuss their legal options for filing their own DePuy ASR lawsuit. To learn more about the DePuy ASR recall, please visit the Firm’s website, or call 800-511-5092 to arrange for a free, no-obligation case review.

*nytimes.com/2013/11/20/business/johnson-johnson-to-offer-2-5-billion-hip-device-settlement.html, New York Times, November 20, 2013

About Bernstein Liebhard LLP
Bernstein Liebhard LLP is a New York-based law firm exclusively representing injured persons in complex individual and class action lawsuits nationwide since 1993, including those who have been harmed by dangerous drugs, defective medical devices and consumer products. The firm has been named by The National Law Journal to the “Plaintiffs’ Hot List,” recognizing the top plaintiffs’ firms in the country, for the past 11 consecutive years.

Bernstein Liebhard LLP
10 East 40th Street
New York, New York 10016
800-511-5092

ATTORNEY ADVERTISING. © 2013 Bernstein Liebhard LLP. The law firm responsible for this
advertisement is Bernstein Liebhard LLP, 10 East 40th Street, New York, New York 10016, 800-511-5092. Prior results do not guarantee or predict a similar outcome with respect to any future matter.
###

Contact Information:
Felecia L. Stern, Esq.
Bernstein Liebhard LLP
info(at)consumerinjurylawyers(dot)com
http://www.consumerinjurylawyers.com
https://plus.google.com/115936073311125306742?rel=author

Read the full story at http://www.prweb.com/releases/depuy-asr-lawsuit/depuy-asr-settlement/prweb11400412.htm.


'/>"/>
Source: PRWeb
Copyright©2012 Vocus, Inc.
All rights reserved

Related medicine news :

1. DePuy Hip Settlement News: Number of Federal Pinnacle Cases Now Exceeds 5,000, Rottenstein Law Group LLP Reports
2. DePuy Pinnacle Hip Lawsuit News: Bernstein Liebhard LLP Notes Order Delaying Consideration of Remand Motions in Federal Pinnacle Hip Litigation
3. DePuy Pinnacle Lawsuit Claims Mount, as Bernstein Liebhard LLP Notes Nearly 6,000 Filings in Federal Pinnacle Hip Litigation
4. DePuy ASR Lawsuit Settlement Update: Rottenstein Law Group LLP Comments on Report of Proposed Additional Compensation
5. DePuy Settlement Update: DePuy Pinnacle Lawsuits Progress in Federal Court, Rottenstein Law Group LLP Reports
6. DePuy ASR Lawsuit Settlement Update: Retired Judge Selected As Claims Administrator, Rottenstein Law Group LLP Reports
7. DePuy ASR™ MDL Lawsuit Update: Settlement Reached in the DePuy ASR™ Hip Implant Multidistrict Litigation (MDL 2197)
8. Chicago Personal Injury Firm of Salvi, Schostok and Pritchard P.C. Calls Attention to Proposed $2.5 Billion DePuy Hip Implant Settlement
9. DePuy ASR Lawsuit Settlement Proposal Moves Forward, as Bernstein Liebhard LLP Notes Issuance of New Order in Federal DePuy ASR Recall Litigation
10. DePuy ASR Settlement News: Bernstein Liebhard LLP Notes Appointment of Special Masters, Claims Administrator to Oversee Proposed DePuy ASR Lawsuit Settlement
11. DePuy ASR Lawsuit Settlement News: Johnson & Johnson Deal Still Leaves Opportunity to File Lawsuits, Notes Rottenstein Law Group LLP
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:4/28/2017)... , ... April 28, 2017 , ... ... been previously exposed to more adverse experiences than children in the general population. ... such as abuse, neglect or other family challenges. While no fault of their ...
(Date:4/28/2017)... ... April 28, 2017 , ... Early detection and elimination ... safety and minimize the cost of development. In this webinar, sponsored by Molecular ... lines and for cardiac toxicity using induced pluripotent stem cells (iPSCs). , In ...
(Date:4/28/2017)... ... April 28, 2017 , ... Yisrayl Hawkins, Pastor and Overseer at The House of Yahweh in ... responds to and which He does not. Yisrayl says with so many titles and ... true name, but he says with a little Scripture, backed with a lot of research, ...
(Date:4/28/2017)... ... April 28, 2017 , ... Intellitec Solutions announced the ... implement a Microsoft Dynamics GP solution that integrates to their PointClickCare EHR software ... in long-term care, Brooke Grove now has the capability to achieve its goal ...
(Date:4/28/2017)... , ... April 28, 2017 , ... Rob Lowe is ... now he has leant his presence to an educational purpose as the host of ... important one being cancer. In a recent episode, the series focuses on thyroid cancer. ...
Breaking Medicine News(10 mins):
(Date:4/20/2017)... 20, 2017 Research and Markets has ... Manufacturing Services Market Analysis By Service (Manufacturing, Research), By Country, ... - 2025" report to their offering. ... The Latin American pharmaceutical contract manufacturing ... 2025 Low drug registration cost in Latin American ...
(Date:4/19/2017)... 19, 2017 The Mobile X-Ray product segment is ... CAGR during the forecast period Mobile X-Ray segment ... digital mobile X-Ray devices market, which is estimated to be ... at a CAGR of 7% over the forecast period. Mobile ... more than US$ 100 Mn in 2017 over 2016. The ...
(Date:4/19/2017)... YORK , April 19, 2017 ... This report on the prostate cancer therapeutics ... the global market. Increasing prevalence of prostate cancer, ... innovation in the development of new drugs & ... prostate cancer drug due to lesser side effects ...
Breaking Medicine Technology: